It has been shown that EGFR and its ligands are overexpressed in many cancers, such as breast cancer, gastric cancer, ovarian cancer, colorectal cancer, and non-small-cell lung carcinoma [18]. This evidence concerns the gene EGFR and ovarian carcinoma.